YPH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Astellas Pharma Inc

Watchlist Manager

Watchlist

Price: 12.92 EUR 0.31% Market Closed

Market Cap: €37.3B

A	Astellas Pharma Inc XMUN:YPH	JP
	Stem Inc NYSE:STEM	US
	Bagger Dave's Burger Tavern Inc OTC:BDVB	US
	Wintrust Financial Corp NASDAQ:WTFC	US
F	Fair Value REIT-AG F:FVI	DE

Profitability Summary

Astellas Pharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

81%

Strong 3Y Average Gross Margin

81%

Declining Gross Margin

82% > 81%

Healthy Operating Margin

21%

Sustainable 3Y Average Operating Margin

10%

Operating Margin is Increasing

13% > 21%

Healthy Net Margin

16%

Low 3Y Average Net Margin

Net Margin is Increasing

7% > 16%

Exceptional Free Cash Flow Margin

20%

Strong 3Y Average Free Cash Flow Margin

11%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.